Latest News

Mar 13, 2019

Propanc Biopharma Receives Notice of Allowance for Additional Claims from Foundation Patent in the U.S.

Pharmaceutical Compositions for Treating Cancer Comprising Trypsinogen and Chymotrypsinogen Confirmed as Patentable MELBOURNE, Australia, March 13, 2019 /PRNewswire/ -- Propanc Biopharma, Inc. (OTCQB: PPCB)…

View All Press Releases